Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1985 1
1987 1
1991 1
1992 2
1995 2
1997 2
1998 1
1999 3
2000 1
2001 1
2002 2
2003 3
2004 1
2005 1
2006 3
2007 4
2008 1
2009 2
2010 5
2011 4
2012 1
2013 2
2014 3
2015 8
2016 5
2017 4
2018 4
2019 4
2020 6
2021 9
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Olmsted syndrome 2"
Page 1
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Baden LR, et al. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378609 Free PMC article. Clinical Trial.
The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19. ...
The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protei …
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group. El Sahly HM, et al. N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22. N Engl J Med. 2021. PMID: 34551225 Free PMC article. Clinical Trial.
The primary end point was prevention of Covid-19 illness with onset at least 14 days after the second injection in participants who had not previously been infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The data cutoff date was March 26, 20 …
The primary end point was prevention of Covid-19 illness with onset at least 14 days after the second injection in participants who had not …
Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability.
Johnson SA, Shouman K, Shelly S, Sandroni P, Berini SE, Dyck PJB, Hoffman EM, Mandrekar J, Niu Z, Lamb CJ, Low PA, Singer W, Mauermann ML, Mills J, Dubey D, Staff NP, Klein CJ. Johnson SA, et al. Neurology. 2021 Nov 30;97(22):e2236-e2247. doi: 10.1212/WNL.0000000000012894. Epub 2021 Oct 27. Neurology. 2021. PMID: 34706972 Free PMC article.
We wished to determine SFN incidence, prevalence, comorbid conditions, longitudinal impairments, and disabilities. METHODS: Test-confirmed patients with SFN in Olmsted, Minnesota, and adjacent counties were compared 3:1 to matched controls (January 1, 1998-December 31, 201 …
We wished to determine SFN incidence, prevalence, comorbid conditions, longitudinal impairments, and disabilities. METHODS: Test-confirmed p …
Prevalence, symptoms and risk factor profile of rumination syndrome and functional dyspepsia: a population-based study.
Zand Irani M, Jones MP, Halland M, Herrick L, Choung RS, Saito Loftus YA, Walker MM, Murray JA, Talley NJ. Zand Irani M, et al. Aliment Pharmacol Ther. 2021 Dec;54(11-12):1416-1431. doi: 10.1111/apt.16630. Epub 2021 Oct 9. Aliment Pharmacol Ther. 2021. PMID: 34626489 Free PMC article.
Prevalence of associations, and univariate and independent associations with predictors were assessed by logistic regression. RESULTS: Prevalence of rumination syndrome and FD were 5.8% and 7.1%, respectively; the overlap was 3.83-times more likely than expected by …
Prevalence of associations, and univariate and independent associations with predictors were assessed by logistic regression. RESULTS …
Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study.
Stang CD, Turcano P, Mielke MM, Josephs KA, Bower JH, Ahlskog JE, Boeve BF, Martin PR, Upadhyaya SG, Savica R. Stang CD, et al. J Parkinsons Dis. 2020;10(1):179-184. doi: 10.3233/JPD-191744. J Parkinsons Dis. 2020. PMID: 31594251 Free PMC article.
OBJECTIVE: To examine the incidence of and trends in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) in a population-based cohort of residents of Olmsted County, MN. METHODS: We used the 1991-2005 population-based, Olmsted County Parkinso …
OBJECTIVE: To examine the incidence of and trends in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) in a popula …
Epidemiology of Guillain-Barre syndrome.
Schoenberg BS. Schoenberg BS. Adv Neurol. 1978;19:249-60. Adv Neurol. 1978. PMID: 369322 Review.
The only measures of morbidity for Guillain-Barre syndrome in well-defined populations in the continental United States come from Olmsted County, Minnesota, and San Joaquin County, California. ...Only two case-control comparisons have been carried out which reveal a …
The only measures of morbidity for Guillain-Barre syndrome in well-defined populations in the continental United States come from …
Incidence and de novo mutation rate of Marfan syndrome and risk of ectopia lentis.
Cui RZ, Hodge DO, Mohney BG. Cui RZ, et al. J AAPOS. 2023 Oct;27(5):273.e1-273.e4. doi: 10.1016/j.jaapos.2023.07.006. Epub 2023 Sep 15. J AAPOS. 2023. PMID: 37716433
PURPOSE: To investigate the population-based incidence and de novo mutation rate of Marfan syndrome and risk of ectopia lentis. METHODS: Patients newly diagnosed with Marfan syndrome in Olmsted County, Minnesota, from January 1, 1976, through December 31, 200 …
PURPOSE: To investigate the population-based incidence and de novo mutation rate of Marfan syndrome and risk of ectopia lentis. METHO …
Incidence of Sturge-Weber syndrome and associated ocular involvement in Olmsted County, Minnesota, United States.
Rihani HT, Dalvin LA, Hodge DO, Pulido JS. Rihani HT, et al. Ophthalmic Genet. 2020 Apr;41(2):108-124. doi: 10.1080/13816810.2020.1731834. Epub 2020 Mar 31. Ophthalmic Genet. 2020. PMID: 32233696 Free PMC article.
Background: Sturge-Weber syndrome (SWS) is a rare sporadic syndrome characterized by nevus flammeus (port-wine stain, PWS) in the trigeminal nerve distribution, diffuse choroidal hemangioma, and brain leptomeningeal hemangioma. ...Incidence of SWS was calculated usi …
Background: Sturge-Weber syndrome (SWS) is a rare sporadic syndrome characterized by nevus flammeus (port-wine stain, PWS) in …
Olmsted's syndrome.
Armstrong AP, Percival N. Armstrong AP, et al. J R Soc Med. 1997 Feb;90(2):81-2. doi: 10.1177/014107689709000208. J R Soc Med. 1997. PMID: 9068437 Free PMC article. No abstract available.
Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes.
Shah S, Flanagan EP, Paul P, Smith CY, Bryant SC, Devine MF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Shah S, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Dec 22;9(2):e1124. doi: 10.1212/NXI.0000000000001124. Print 2022 Mar. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34937736 Free PMC article.
OBJECTIVES: Population-based epidemiologic data for paraneoplastic neurologic syndromes (PNSs) in the United States are lacking. Our objective was to evaluate the incidence, prevalence, and associated morbidity of PNS. ...RESULTS: There were 28 patients with PNS identified …
OBJECTIVES: Population-based epidemiologic data for paraneoplastic neurologic syndromes (PNSs) in the United States are lacking. Our …
84 results